Why This Analyst Sees Over 40% Upside in Tesla
Tesla closed out the week on a positive note after the firm received an incredibly bullish call. In fact, the target issued is the new street high.
All Work
Chris Lange
Even More Biopharma and FDA Catalysts Coming in October
24/7 Wall St. has collected a few more catalysts that are coming up in October for biotech and pharmaceutical companies.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a relatively flat day for the U.S. markets with all major exchanges pulling back, if only marginally, from their record all-time highs. Crude fell again and posted its first weekly loss in…
Can Costco Fight Back Against Amazon?
Retailers have been at the mercy of Amazon and its e-commerce empire for the last couple of years, but as we said before, Costco might have found a way to fight back.
Why Analysts Are Cooling Off on Netflix
Jefferies was one of the first firms to tackle Netflix’s price hike and why it is on the sideline about this stock.
Costco Earnings Aren’t Enough Despite Strong Beat
After Costco reported its fiscal fourth-quarter financial results, the share price pulled back early Friday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a strong day for the U.S. markets with all major exchanges hitting record all-time highs. Crude oil finally fought back and pushed back over $50, but it still could close out the…
What to Expect When Costco Reports After the Close
Costco is scheduled to release its most recent quarterly earnings report after the markets close on Thursday. What can investors expect?
Why Netflix Is Quietly Hiking Its Prices
Netflix quietly said that it would raise the price for its monthly streaming service in the United States. Although the price increase isn’t that much per customer, it adds up over more than 100…
How Amazon Is Now Threatening FedEx and UPS
Amazon shares saw a nice bump on Thursday on reports that it is experimenting with its own delivery service.
Americans Spend Less on Transportation Than 3 Decades Ago
It’s no doubt that Americans spend a lot of money on transportation, but these costs have been surprisingly shrinking over the past three decades.
Why ImmunoGen’s Secondary Makes Sense
ImmunoGen saw its shares make a sharp turn downward on Thursday morning after the stock has seen an incredible year of trading so far.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a flat day for the U.S. markets although all major averages hit record all-time highs in the session. Crude oil continued to fall, this time below $50, and it looks like oil…
What CytomX Gets From Its Huge Amgen Collaboration
CytomX Therapeutics shares made a solid gain in Wednesday’s session following announcement of a strategic collaboration with Amgen in immuno-oncology.
How Office Depot Is Taking a New Strategic Direction
Office Depot saw its shares dip on Wednesday after the firm announced that it would be changing its business model and taking a new strategic direction.
Meet Tesla’s Most Bullish Call on the Street
Tesla is perhaps one of the most favorite cult stocks in the market today. It has consistently posted losses year after year, yet investors still flock to this company.
Amicus Therapeutics Wins Big at World Muscle Society Conference
Amicus Therapeutics is another biotech player seeing a nice boost from the World Muscle Society Conference in France.
Why Catabasis Shares Are Surging
Catabasis Pharmaceuticals shares continued their incredible climb after the announcement of positive efficacy results from its MoveDMD trial in a late-breaking session at the World Muscle Society Conference in France.
Is This the Turnaround That Mylan Has Waited For?
Finally some good news out of Mylan, which potentially is bringing the shares back to about even for 2017.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was another positive day for the U.S. markets with all of the major averages hitting record all-time highs in the session. Crude oil continued to back off and looking like it might not…